Initial clinical experience with the Protégé EverFlex™ long self-expanding nitinol stent in the superficial femoral artery

Journal of Interventional Cardiology

Volumn 19, Issue 6, 2006, Pages 544-546

  Ruef, Johannes ^a   Hofmann, Manfred ^a   Haase, Jürgen ^a  

^a Red Cross Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL;

ADULT; AGED; ARTERY DILATATION; ARTERY OCCLUSION; ARTICLE; CLAUDICATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; MALE; PRIORITY JOURNAL; STENT; SUPERFICIAL FEMORAL ARTERY; TREATMENT OUTCOME; VASCULAR ACCESS;

AGED; ALLOYS; ARTERIAL OCCLUSIVE DISEASES; FEMALE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; STENTS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 33750865938     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2006.00197.x     Document Type: Article

References (4)

1. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal balloon angioplasty. J Vasc Surg 1997;25:74-83.
2. Vogel TR, Shindelan LE, Nackman GB, et al. Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg 2003;38:1178-1184.
3. Ruef J, Hofmann M, Haase J. Endovascular interventions in iliac and infrainguinal occlusive artery disease. J Interven Cardiol 2004;17:427-435.
4. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;46:312-315.